NewsRoom Articles - Page 121 of 154 - PsychedelicNewsWire (PNW)

TuesdaySep 08, 2020 4:15 pm

Poll Reveals 60% of DC Voters Support Psychedelic Ballot Initiative

A new survey has revealed that every three in five voters residing in Washington, D.C. are in favor of a proposal to decriminalize a large range of psychedelics. Since the last poll that was carried out in April, the results from the most recent poll show that support for the initiative rose significantly by 9% as more and more individuals learned about the measure. Of the total number of respondents, 60% stated that they’d vote for the Initiative 81, which seeks to decriminalize entheogenic substances like ayahuasca and psilocybin mushrooms. The remaining 40% was split between those who voted no,…

FridaySep 04, 2020 3:30 pm

The Jungle, War Wounds and Psychedelic Therapy

As many soldiers return home with their souls in pieces and having no sense of self, many decline to use anti-depressants because of the many effects they have and instead, choose to imbibe and drown themselves in liquor, hoping to numb the pain without getting to the root cause and dealing with it in order to begin the healing process. However, in Western Costa Rica, psychedelic-assisted healing retreats such as the Soltara Healing Center, provide an alternative solution to antidepressants as well as other commonly prescribed pharmaceuticals with the use of ayahuasca, a hallucinogenic brew. Indigenous communities of the Amazonian…

ThursdaySep 03, 2020 3:30 pm

Organic vs. Synthetic Psychedelic Drugs: What Will Consumers Prefer?

Manufactured drugs are developed with efficacy and precision in mind. Psychedelic medications on the other hand aren’t as reliable seeing as different people have different experiences using these drugs and additionally, using psychedelics sometimes is taxing on an individual’s body. For this reason, many are now looking into synthetic psychedelics. However, it is unknown whether synthetic psychedelics will have as many consumers as plant-based medication has. What is the difference between the two? Well there’s the obvious one, natural psychedelics are plants grown and ingested as they are while synthetic psychedelics are laboratory made. As the debate between the two…

WednesdaySep 02, 2020 3:52 pm

Study Shows That Psychedelic Drugs Decrease Depressive Symptoms

The latest research gives preliminary confirmation that psychedelic drugs can better an individual’s mental health by making them more accepting of experiences that are distressing. Frontiers in Psychiatry published the study, adding to an already expanding body of literature which shows that utilizing substances such as psilocybin can improve symptoms of depression. Therapy using psychedelics has shown a lot of potential for treating various mental health disorders, such as major depressive disorder, substance use disorders and distress related to a life-threatening ailment. As compared to pharmacological use of drugs to treat different mental health issues, psychedelic therapy results last anywhere…

TuesdaySep 01, 2020 12:15 pm

Daily Practice, Community and Psychedelic Integration

Integration is a very significant aspect of inner work, especially with regard to psychedelics. It involves an individual figuring out the many rewards of self that come with deep inner work, how to balance it out in the real world and receiving support as one comprehends these new revelations. Mostly, intense inner work is usually carried out in sessions or workshops. However, the process carries over even after the session is completed. This is the crucial part as it involves a lot of intense material or emotions and an individual is supposed to allow themselves the time to work through…

MondayAug 31, 2020 12:29 pm

Cybin Corp. at Forefront of Change in Psilocybin-Based Treatments

Company focused on furthering R&D of psilocybin-based medications Cybin believes psychedelic substances derived from mushrooms can work as boosters for brain Psilocybin shows promise for an array of mental health issues Cybin Corp. is a leading life-science company focused on psychedelic and nutraceutical products to support various psychiatric and neurological conditions. The company is engaged in clinical trials, through a partnership with the Toronto Centre for Psychedelic Science (“TCPS”) to gain regulatory approval for psilocybin and other psychedelic products (http://ibn.fm/RgpQc). In the 1940s, the study of psychedelic drugs for the treatment of mental health conditions began with the discovery of LSD.…

MondayAug 31, 2020 11:05 am

Pure Extract Technologies Inc. Ideally Positioned to Become Leader in White Label Market

Company’s Standard Processing License pending approval from Health Canada After licensing approval, Pure Extracts will be launching white label production as part of core services Pure Extracts facility designed to produce high-quality, high-purity formulations on a commercial scale Pure Extract Technologies, a Canadian plant-based extraction company operating in the functional medicinal mushrooms space, is preparing to become a leading contender in the white labeling space. The Company’s Standard Processing License is currently pending approval from Health Canada; upon approval the Company will be launching white label production as part of its core services. As an expert in the extraction field,…

MondayAug 31, 2020 10:00 am

Psychedelics, Ego Death and the Brain

Contemporary neuroscience has shown that psychedelics like psilocybin, LSD and ayahuasca significantly decrease activity in the brain’s DMN (default mode network). This decline in DMN action in a way reboots one’s brain and is associated with one of the lasting therapeutic effects of psychedelic substances. The DMN is an interlinked group of brain regions that are linked to introspective functions and internally directed thoughts like self-criticism and self-reflection. The practical connections that constitute the DMN grow between birth and adulthood. It is not until the age of five that a child develops ‘ego’ or a stable sense of narrative self.…

FridayAug 28, 2020 12:15 pm

Congressman Helps Raise Money to Legalize Psilocybin Mushroom Therapy

The representative for Oregon's 3rd Congressional district Earl Francis Blumenauer, who is a chief advocate for cannabis reform, formally announced his support of Oregon’s initiative to legalize psilocybin mushrooms to be used for therapeutic purposes. He is also helping to raise money for the company. He stated in a mass email that he fully supported the measure as it addresses mental health which is key issue in the community, in a responsible and innovative way. Additionally, he stated that the legalization of psilocybin therapy was an important tool that deserved everyone’s support. The measure in question, Measure 109, provides residents…

ThursdayAug 27, 2020 2:45 pm

Mental Health: The Second Pandemic. Is Psychedelic-Assisted Therapy the Answer?

Largely due to the COVID-19 pandemic and the lockdowns imposed in various jurisdictions around the world, mental health issues have become the new topic of discussion. According to the Journal of the American Psychiatric Nurses Association, the psychological torrent from COVID-19 is likely to develop into a completely distinct pandemic of its own. Other organizations such as the United Nations and World Health Organization have also cited the possible mental health emergency as something that should not be ignored. A study carried out by JAPNA highlights the need for new and better mental health interpositions as a way to prepare…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000